You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

Article metrics

Article menu

This article has corrections. Please see:

Download PDFPDF

XML
Editorial
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

 

Online download statistics by month:

Online download statistics by month: April 2020 to September 2025

AbstractFullPdf
Apr 2020049641544
May 202002515824
Jun 202001129200
Jul 20200621104
Aug 2020048978
Sep 20200520139
Oct 2020047197
Nov 2020032062
Dec 2020045787
Jan 2021042980
Feb 2021040460
Mar 2021045290
Apr 2021040661
May 2021044273
Jun 2021040150
Jul 2021030846
Aug 2021035974
Sep 2021035443
Oct 2021036777
Nov 2021033678
Dec 2021033836
Jan 2022031131
Feb 2022028844
Mar 2022015135
Apr 2022016134
May 2022010628
Jun 2022013330
Jul 2022021823
Aug 2022018738
Sep 2022016626
Oct 2022019633
Nov 2022016831
Dec 2022015025
Jan 2023016939
Feb 2023015626
Mar 2023019924
Apr 2023015031
May 2023016119
Jun 2023010511
Jul 2023011122
Aug 202309923
Sep 2023010716
Oct 2023014212
Nov 2023013711
Dec 2023029131
Jan 202408679
Feb 202409253
Mar 2024013286
Apr 2024012251
May 2024012739
Jun 2024011520
Jul 2024011935
Aug 2024026427
Sep 202408729
Oct 202409230
Nov 2024012424
Dec 2024012618
Jan 2025012844
Feb 2025018722
Mar 2025012924
Apr 2025016834
May 2025012232
Jun 202509938
Jul 2025010
Aug 2025010
Sep 2025010
Total0224665231